Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
aimmune therapeutics
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
4
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
indiana blog main
indiana top stories
national
andrew oxtoby
cancer immunotherapy
eli lilly
gene therapy
glaxosmithkline
immunotherapy
palforzia
vertex pharmaceuticals
abbvie
advaxis
What
bio
roundup
bucks
corner
week
abbvie’s
agency
ahead
aimmune
allergy
approval
approved
arena’s
awarded
big
biofourmis
bosley's
bosley’s
bounty
bridge
cancer
cas
celebrate
ceo
chance
cig
comeback
companies
crime
crispr
day
days
deals
delivered
departure
developed
drug
editas
exit
expressing
Language
unset
Current search:
fda
×
" aimmune therapeutics "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More